Wen Lai Zhou
Corporate Officer/Principal at JACOBIO PHARMACEUTICALS GROUP CO., LTD.
Profile
Wen Lai Zhou is the founder of Beijing Danqin Pharma Technology Co., Ltd.
He currently holds the position of Director at Beijing Jiakesi New Drug Development Co. Ltd., Director at Jacobio Hk Pharmaceuticals Co. Ltd., and Chief Biologist Officer & Senior Vice President at Jacobio Pharmaceuticals Group Co., Ltd.
Dr. Zhou previously worked as an Associate at Howard Hughes Medical Institute, Inc. from 2005 to 2007 and as the Head-Laboratory at Novartis Institutes for Biomedical Research, Inc. from 2009 to 2014.
He obtained a doctorate degree from the University of Melbourne in 2003 and completed his undergraduate and graduate degrees at Xinjiang University in 1988 and 1991 respectively.
Wen Lai Zhou active positions
Companies | Position | Start |
---|---|---|
JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Corporate Officer/Principal | 31/07/2020 |
Beijing Jiakesi New Drug Development Co. Ltd.
Beijing Jiakesi New Drug Development Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Jiakesi New Drug Development Co. Ltd. develops and sells drugs. The company was founded by Yinxiang Wang on July 17, 2015 and is headquartered in Beijing, China. | Director/Board Member | 31/07/2018 |
Jacobio Hk Pharmaceuticals Co. Ltd. | Director/Board Member | 31/07/2018 |
Beijing Danqin Pharma Technology Co., Ltd.
Beijing Danqin Pharma Technology Co., Ltd. BiotechnologyHealth Technology Beijing Danqin Pharma Technology Co., Ltd. is an innovative drug research and development company that focuses on precision targeting tumor targets in the 2.0 era. The company was founded in 2021 and is based in Beijing, China. The Chinese company's goal is to develop drugs that meet patients' clinical needs and promote medical innovation. The company's new pharmaceutical projects in the world's first (FIC) drug projects are under research, with scientific research platforms such as drug design, chemical synthesis, pharmacological research, pharmacological metabolism and security evaluation, drug analysis, patent, and registration. The company was founded by Wen Lai Zhou, Hong Mei Li, Dan Yan, Jin Cong Zhuo, and Wen Lai Zhou has been the CEO since incorporation. | Chief Executive Officer | - |
Former positions of Wen Lai Zhou
Companies | Position | End |
---|---|---|
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 31/10/2014 |
Howard Hughes Medical Institute, Inc.
Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Howard Hughes Medical Institute, Inc. engages in the provision of biomedical research services and science education programs. It funds grants to both institutions and individuals in support of a wide range of science and research-related initiatives, including precollege and undergraduate science education, pre- and post-doctoral research fellowships, and international research activities. The company was founded by Howard R. Hughes in 1953 and is headquartered in Chevy Chase, MD. | Corporate Officer/Principal | 31/05/2007 |
Training of Wen Lai Zhou
University of Melbourne | Doctorate Degree |
Xinjiang University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Health Technology |
Private companies | 5 |
---|---|
Howard Hughes Medical Institute, Inc.
Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Howard Hughes Medical Institute, Inc. engages in the provision of biomedical research services and science education programs. It funds grants to both institutions and individuals in support of a wide range of science and research-related initiatives, including precollege and undergraduate science education, pre- and post-doctoral research fellowships, and international research activities. The company was founded by Howard R. Hughes in 1953 and is headquartered in Chevy Chase, MD. | Miscellaneous |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
Beijing Jiakesi New Drug Development Co. Ltd.
Beijing Jiakesi New Drug Development Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Jiakesi New Drug Development Co. Ltd. develops and sells drugs. The company was founded by Yinxiang Wang on July 17, 2015 and is headquartered in Beijing, China. | Health Technology |
Jacobio Hk Pharmaceuticals Co. Ltd. | |
Beijing Danqin Pharma Technology Co., Ltd.
Beijing Danqin Pharma Technology Co., Ltd. BiotechnologyHealth Technology Beijing Danqin Pharma Technology Co., Ltd. is an innovative drug research and development company that focuses on precision targeting tumor targets in the 2.0 era. The company was founded in 2021 and is based in Beijing, China. The Chinese company's goal is to develop drugs that meet patients' clinical needs and promote medical innovation. The company's new pharmaceutical projects in the world's first (FIC) drug projects are under research, with scientific research platforms such as drug design, chemical synthesis, pharmacological research, pharmacological metabolism and security evaluation, drug analysis, patent, and registration. The company was founded by Wen Lai Zhou, Hong Mei Li, Dan Yan, Jin Cong Zhuo, and Wen Lai Zhou has been the CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- Wen Lai Zhou